In this cohort, 12 of the 14 patients (85.7%) with ROHHAD syndrome were positive for anti-ZSCAN1 autoantibodies (Figure 2). This evidence concerns the gene ZSCAN1 and rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome.